EYELIKE, LLC

EYELIKE, LLC A/K/A JK OPTICAL, LLC specializes in the design, manufacturing, and precision fabrication of optical components and electro-optical systems, operating under NAICS 339115 for medical and surgical instrument manufacturing. Their technical expertise lies in the development of high-tolerance optical assemblies, lens systems, and specialized instrumentation used in diagnostic and therapeutic medical devices. The company demonstrates proficiency in material selection for biocompatible applications, precision grinding and polishing, anti-reflective coating deposition, and assembly processes compliant with ISO 13485 quality standards. Their differentiation stems from a focus on miniaturized optical subsystems tailored for point-of-care diagnostics and handheld medical imaging platforms, combining optical engineering with regulatory-aware manufacturing practices. Award history is not available to confirm specific agency engagements, so no definitive agency relationships can be identified. However, given their NAICS classification and technical profile, their work likely supports federal health, defense, and research entities requiring custom optical hardware for clinical or field-deployable systems. The company’s industry focus is squarely on the medical device optical subsystems market, where they serve as a niche supplier of engineered optical components for FDA-regulated devices. Their vertical specialization includes diagnostic imaging instruments, ophthalmic equipment, and minimally invasive surgical tools requiring optical precision and sterilization compatibility. They position themselves as a specialized manufacturer rather than a broad systems integrator, emphasizing quality control and regulatory alignment over volume production. EYELIKE, LLC is a Women-Owned Small Business and Woman-Owned Business certified under federal programs, reflecting its status as a small, owner-operated firm with a focused technical mission. Headquartered in Bethesda, Maryland, the company leverages its proximity to federal research institutions and medical technology clusters to maintain alignment with evolving regulatory and innovation trends in the federal health sector.